Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1298 (LINC01298, also known as C8orf69) is a **long intergenic non-coding RNA (lincRNA)** gene, transcribed into RNA molecules >200 nucleotides that do not encode proteins[1][3]. LincRNAs like LINC01298 are recognized for their roles in the regulation of gene expression, frequently through modulation of chromatin remodeling and influencing transcriptional programs; some can also act as enhancers or scaffolds for chromatin modification complexes[3][5]. While lincRNAs as a class—including LINC01298—have been linked to various functions in gene regulation and disease contexts such as cancer, there is **no evidence that LINC01298 itself functions as a canonical therapeutic target** (e.g., enzyme, receptor, transporter)[1][5]. Its roles are currently understood as regulatory RNAs rather than direct drug targets or protein-coding genes. No drugs are known to interact directly with LINC01298, and it is not employed as a standard biomarker or considered to pose unique safety concerns at this time[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1298 (LINC01298).